Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital, Nottingham, United Kingdom.
Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital, Nottingham, United Kingdom.
Pathology. 2018 Jan;50(1):100-110. doi: 10.1016/j.pathol.2017.10.005. Epub 2017 Nov 26.
Papillary lesions of the breast comprise a heterogeneous group of diseases ranging from benign and atypical lesions to malignant tumours including non-invasive and invasive entities. Although diagnosis of papillary lesions featuring typical histological features is straightforward, a proportion shows overlapping features, posing diagnostic challenges. In addition to being uncommon, the excellent behaviour of papillary tumours reduces the distinguishing value of individual histological features and increases the subjectivity of interpretation of various diagnostic features. Therefore the overall categorisation, which is based on a constellation of subjective features, may vary with subsequent management implications. Concordance studies revealed that recognition of papillary carcinomas (PC) as a malignant entity by pathologists is high, but concordance of its classification into in situ and invasive disease can be problematic, as can assessment of prognostic and predictive factors in the invasive component. Identification of low nuclear grade atypia within benign papillary lesions and its classification into atypia or in situ carcinoma may also pose a diagnostic challenge. Although immunohistochemistry is helpful in evaluation of benign and atypical lesions it has a limited utility in differentiating the majority of PC as non-invasive or invasive disease. Pathologists should be aware of the various entities and the differential diagnosis of each entity, the existence of lesions with overlapping features and should follow the updated guideline recommendation for their diagnosis and management. These rare lesions usually require additional diagnostic work-up and difficult cases should trigger consensus opinion or expert referral.
乳腺的乳头状病变包含一组异质性疾病,从良性和非典型病变到恶性肿瘤,包括非浸润性和浸润性实体。虽然具有典型组织学特征的乳头状病变的诊断是直接的,但一部分病变具有重叠的特征,这构成了诊断挑战。除了罕见之外,乳头状肿瘤的良好行为降低了单个组织学特征的鉴别价值,并增加了各种诊断特征解释的主观性。因此,基于主观特征的整体分类可能因后续管理的影响而有所不同。一致性研究表明,病理学家将乳头状癌 (PC) 识别为恶性实体的能力较高,但将其分类为原位和浸润性疾病的一致性可能存在问题,侵袭性成分中预后和预测因素的评估也是如此。在良性乳头状病变中识别低核级异型性并将其分类为异型性或原位癌也可能构成诊断挑战。虽然免疫组织化学在评估良性和非典型病变方面很有帮助,但它在区分大多数 PC 为非浸润性或浸润性疾病方面的作用有限。病理学家应该了解各种病变和每种病变的鉴别诊断,存在具有重叠特征的病变,并应遵循最新的指南建议进行诊断和管理。这些罕见的病变通常需要额外的诊断检查,而困难的病例应引发共识意见或专家转诊。